These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4598059)

  • 21. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
    Zweifler A; Esler M
    Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alprenolol and propranolol in the treatment of hypertension: a comparative study.
    Somer T; Luomanmäki K; Frick MH
    Acta Med Scand Suppl; 1974; 554():33-7. PubMed ID: 4593671
    [No Abstract]   [Full Text] [Related]  

  • 23. Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
    Morgan T; Carney S; Roberts R
    Clin Sci Mol Med Suppl; 1975 Jun; 2():81s-83s. PubMed ID: 802647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic effect of propranolol therapy in relationship to renin status and plasma catecholamines in primary hypertension.
    Vlachakis ND
    J Clin Pharmacol; 1980 Jan; 20(1):20-9. PubMed ID: 6987282
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol.
    Esler M; Zweifler A; Randall O; DeQuattro V
    Clin Pharmacol Ther; 1977 Sep; 22(3):299-308. PubMed ID: 330078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: Propranolol again: order out of chaos?
    Krakoff LR
    N Engl J Med; 1976 Jul; 295(2):102. PubMed ID: 775329
    [No Abstract]   [Full Text] [Related]  

  • 27. Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
    Karlberg BE; Kågedal B; Tegler L; Tolagen K; Bergman B
    Am J Cardiol; 1976 Mar; 37(4):642-9. PubMed ID: 769527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol therapy in essential hypertension.
    Lydtin H; Kusus T; Daniel W; Schierl W; Ackenheil M; Kempter H; Lohmöller G; Niklas M; Walter I
    Am Heart J; 1972 May; 83(5):589-95. PubMed ID: 4554488
    [No Abstract]   [Full Text] [Related]  

  • 29. Potentiation of renin release by combining renal arterial constriction and beta-adrenergic stimulation.
    Eide I; Löyning E; Kill F
    Scand J Clin Lab Invest; 1974 Dec; 34(4):301-10. PubMed ID: 4460225
    [No Abstract]   [Full Text] [Related]  

  • 30. Propranolol in the control of blood pressure: a dose-response study.
    Serlin MJ; Orme ML; Baber NS; Sibeon RG; Laws E; Breckenridge A
    Clin Pharmacol Ther; 1980 May; 27(5):586-92. PubMed ID: 6102895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol given twice daily in hypertension.
    Berglund G; Andersson O; Hansson L; Olander R
    Acta Med Scand; 1973 Dec; 194(6):513-5. PubMed ID: 4204165
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of guanethidine and propranolol on capillary blood flow in subcutaneous tissue and muscle in essential hypertension.
    Pechan J; Ondrejicka M; Janotka M; Kellerová E
    Cardiology; 1974; 59(3):172-83. PubMed ID: 4447953
    [No Abstract]   [Full Text] [Related]  

  • 33. [Action of increasing doses of DL-propranolol on behavior of arterial pressure and plasma renin activity (PRA)].
    Cerasola G; Morici ML; Amico LM; Biondo S
    Boll Soc Ital Cardiol; 1978; 23(12):2023-34. PubMed ID: 397834
    [No Abstract]   [Full Text] [Related]  

  • 34. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.
    Hamet P; Kuchel O; Cuche JL; Boucher R; Genest J
    Can Med Assoc J; 1973 Dec; 109(11):1099-103. PubMed ID: 4357222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.
    Hansson L; Zweifler AJ; Julius S; Ellis CN
    Int J Clin Pharmacol; 1974 Sep; 10(2):79-89. PubMed ID: 4448555
    [No Abstract]   [Full Text] [Related]  

  • 37. Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.
    Drayer JI; Keim HJ; Weber MA; Case DB; Laragh JH
    Am J Med; 1976 May; 60(6):897-903. PubMed ID: 190882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One and three doses of propranolol a day in hypertension.
    van den Brink G; Boer P; van Asten P; Dorhout Mees EJ; Geyskes GG
    Clin Pharmacol Ther; 1980 Jan; 27(1):9-15. PubMed ID: 7351121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol.
    Drayer JI; Weber MA; Longworth DL; Laragh JH
    Am J Med; 1978 Feb; 64(2):187-92. PubMed ID: 629266
    [No Abstract]   [Full Text] [Related]  

  • 40. Racial difference in response to antihypertensive drugs. A focus on verapamil.
    Cubeddu LX
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):72S-78S. PubMed ID: 3540228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.